For many, the loss of vision would be a hard thing to comprehend, but for one remarkable Toowoomba teenager it marked the ...

The biotech provided an update after the stock market closed Thursday, telling investors that it had been unable to align ...

The burgeoning of research on the dark triad is perhaps unprecedented in psychology. But a new paper explains why it’s ...

Kezar Life Sciences faces FDA delays for AIH drug trials, implements restructuring, and explores strategic alternatives amid ...

As Novartis moves ahead plans to expand Pluvicto's use based on the PSMAddition trial, experts urge for greater use of ...

All monetary amounts are expressed in U.S. dollars, unless otherwise indicated. Toronto, Ontario–(Newsfile Corp. –) – IAMGOLD ...

Kezar Life Sciences, Inc. (Nasdaq: KZR, the Company), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today ...

Lite Strategy, Inc. (NASDAQ: LITS) (“Lite Strategy” or “LITS”), the first U.S.-listed public company to adopt Litecoin as its primary reserve asset, joins the digital asset community in celebrating ...

Kezar Life Sciences (KZR) announced regulatory updates and the initiation of a process to explore a full range of strategic alternatives focused ...

Bullying has plagued schools for generations. The behavior is so deeply engrained that some people even go as far as to ...

The Sydney Paralympic was a watershed moment for the Paralympic movement. A quarter of a century later, Kurt Fearnley, Louise ...

Kezar announced on Thursday that it was unable to align with the FDA on a potential registrational clinical trial of ...